Skip to main content
DaVita10-K: Customer concentration

68% of U.S. dialysis revenue comes from government programs, while all profits are from commercial payors.

What happened

DaVita is heavily dependent on government reimbursement, which constitutes 68% of U.S. dialysis revenue. However, the company states that nearly all of its profits come from the much smaller commercial payor segment, creating significant financial risk if the commercial patient mix declines.

Source

SEC EDGARFeb 11, 2026

Annual report (Form 10-K)

DaVita 10-K for FY2025

Filing excerpt

The sources of our U.S. dialysis revenues are principally from government-based programs... Total government-based programs 68 %

sec.gov/Archives/edgar/data/927066/000092706626000012/dva-20251231.htmRead the full source

Other signals in this filing (11)

Extracted by Autobound

From the Signal API record
Signal
10-K: Customer concentration

What this signalsFilings often name leadership changes, deals and spending plans.

Period
FY2025
Fiscal year end
12/31
Filed
Feb 11, 2026

More 10-K signals at other companies

The full record

From the Signal API record

Numbers

Percent
68% (Percentage of U.S. dialysis revenues from government-based programs)

Details

CIK
927066
Accession number
0000927066-26-000012
Timeframe
Current year
Filing year
2026
Why it matters
Diversification strategy
Signal category
Market

Topics and mentions

Competitors

  • Optum
  • Inc.
  • UnitedHealth Group

Regions named

  • U.S.

Competitors named

  • Optum, Inc.
  • UnitedHealth Group, Inc.

Extraction

Confidence
High
Relevance
90%
Sentiment
Negative
Detected
Feb 17, 2026
signal_type
sec-10k
signal_subtype
customerConcentration

Use this data

Get every 10-K signal for DaVita and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at DaVita this week?”

  2. Send it to your own tools

    The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/9185f2ca-5840-4cc3-b8f6-4512e9c93146 returns this record as JSON. POST /v1/companies/enrich returns every signal for davita.com.

{
  "signal_id": "9185f2ca-5840-4cc3-b8f6-4512e9c93146",
  "signal_type": "sec-10k",
  "signal_subtype": "customerConcentration",
  "detected_at": "2026-02-17T06:37:53.052+00:00",
  "company": {
    "name": "DaVita",
    "domain": "davita.com"
  },
  "data": {
    "detail": "DaVita is heavily dependent on government reimbursement, which constitutes 68% of U.S. dialysis revenue. However, the company states that nearly all of its profits come from the much smaller commercial payor segment, creating significant financial risk if the commercial patient mix declines.",
    "metrics": {
      "pct": 0.68,
      "timeframe": "current_year",
      "pct_context": "Percentage of U.S. dialysis revenues from government-based programs"
    },
    "summary": "68% of U.S. dialysis revenue comes from government programs, while all profits are from commercial payors.",
    "excerpts": "The sources of our U.S. dialysis revenues are principally from government-based programs... Total government-based programs 68 %",
    "relevance": 0.9,
    "sentiment": "negative",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/927066/000092706626000012/dva-20251231.htm",
    "filing_date": "2026-02-11",
    "filing_year": 2026,
    "fiscal_year_end": "12/31",
    "sales_relevance": "Diversification strategy",
    "signal_category": "market",
    "regions_mentioned": [
      "U.S."
    ],
    "competitors_mentioned": [
      "Optum, Inc.",
      "UnitedHealth Group, Inc."
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.